Company: CDLX
Filing Date: 2025-04-03
Form Type: ARS
Source: 0001666071-25-000048
Chunk: 168

Company: Cardlytics, Inc.
Filing Date: 2025-04-03
Form: ARS
Chunk 168
---
 Inducement Plan 10-Q 001-38386 10.8 11/1/2022 10.21† Form of restricted stock unit grant notice and agreement under 2022 Inducement Plan 10-Q 001-38386 10.9 11/1/2022 10.22† Offer Letter Agreement between Amit Gupta and Cardlytics, Inc. 10-K 001-38386 10.41 3/1/2023 10.23† Severance Agreement between Amit Gupta and Cardlytics, Inc. 10-K 001-38386 10.41 3/1/2023 10.24† Amendment to Inducement Plan 10-K 001-38386 10.41 3/1/2023 10.25^ Amendment No. Two to Office Lease Agreement dated as of April 23, 2023, by and between the Registrant and Jamestown Ponce City Market, L.P., as amended to date 10-Q 001-38386 10.4 5/4/2023 10.26 Second Amendment to Inducement Plan S-8 001-38386 4.8 7/18/2023 10.27^ Third Amendment to Schedule #1, dated June 29, 2023, to the Master Agreement by and between the Registrant and JPMorgan Chase Bank, N.A. 10-Q 001-38386 10.1 8/1/2023 10.28† Offer Letter Agreement between Alexis DeSieno and the Registrant dated June 20, 2023 10-Q 001-38386 10.2 8/1/2023 10.29† Separation Pay Agreement between Alexis DeSieno and the Registrant, dated July 13, 2023. 10-Q 001-38386 10.3 8/1/2023 109

10.30 Cooperation Agreement, dated as of September 19, 2023, by and among Cardlytics, Inc. and the investors named therein 8-K 001-38386 10.1 9/19/2023 10.31 Settlement Agreement by and between the Company and Shareholder Representative Services LLC, dated as of January 25, 2024 10-K 001-38386 10.5 3/14